A phase I study of the oral platinum agent satraplatin in combination with weekly docetaxel.
Phase of Trial: Phase I
Latest Information Update: 09 May 2012
At a glance
- Drugs Docetaxel; Satraplatin
- Indications Solid tumours
- Focus Adverse reactions
- 09 May 2012 Actual end date (Mar 2009) added as reported by ClinicalTrials.gov.
- 09 May 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 02 Jun 2008 Results were reported at the ASCO-2008, according to a GPC Biotech media release.